research LB1159 First-in-human clinical trial evaluating AI-09, a novel long-lasting ready-to-use liquid injectable neuromodulator for the treatment of glabellar lines
AI-09 is safe, effective, and reduces wrinkles for up to 6 months.
Incomplete name
Seligenstadt, Hessen, Germany
Incomplete name
Chiang Mai, Thailand
Incomplete name
Phoenix, United States
Warsaw, Poland
Kuala Lumpur, Kuala Lumpur, Malaysia
Taipei City, Taiwan

